159 related articles for article (PubMed ID: 2609067)
81. Long-term persistence of specific T- and B-lymphocyte responses to Borrelia burgdorferi following untreated neuroborreliosis.
Krüger H; Pulz M; Martin R; Sticht-Groh V
Infection; 1990; 18(5):263-7. PubMed ID: 2276818
[TBL] [Abstract][Full Text] [Related]
82. Epitopes on the outer surface protein A of Borrelia burgdorferi recognized by antibodies and T cells of patients with Lyme disease.
Shanafelt MC; Anzola J; Soderberg C; Yssel H; Turck CW; Peltz G
J Immunol; 1992 Jan; 148(1):218-24. PubMed ID: 1370170
[TBL] [Abstract][Full Text] [Related]
83. Ultrastructural demonstration of spirochetal antigens in synovial fluid and synovial membrane in chronic Lyme disease: possible factors contributing to persistence of organisms.
Nanagara R; Duray PH; Schumacher HR
Hum Pathol; 1996 Oct; 27(10):1025-34. PubMed ID: 8892586
[TBL] [Abstract][Full Text] [Related]
84. Rapid typing of Borrelia burgdorferi sensu lato species in specimens from patients with different manifestations of Lyme borreliosis.
Lünemann JD; Zarmas S; Priem S; Franz J; Zschenderlein R; Aberer E; Klein R; Schouls L; Burmester GR; Krause A
J Clin Microbiol; 2001 Mar; 39(3):1130-3. PubMed ID: 11230440
[TBL] [Abstract][Full Text] [Related]
85. Biased T-cell antigen receptor repertoire in Lyme arthritis.
Roessner K; Trivedi H; Gaur L; Howard D; Aversa J; Cooper SM; Sigal LH; Budd RC
Infect Immun; 1998 Mar; 66(3):1092-9. PubMed ID: 9488400
[TBL] [Abstract][Full Text] [Related]
86. Host-pathogen interactions promoting inflammatory Lyme arthritis: use of mouse models for dissection of disease processes.
Wooten RM; Weis JJ
Curr Opin Microbiol; 2001 Jun; 4(3):274-9. PubMed ID: 11378478
[TBL] [Abstract][Full Text] [Related]
87. Demonstration of a B-lymphocyte mitogen produced by the Lyme disease pathogen, Borrelia burgdorferi.
Schoenfeld R; Araneo B; Ma Y; Yang LM; Weis JJ
Infect Immun; 1992 Feb; 60(2):455-64. PubMed ID: 1730476
[TBL] [Abstract][Full Text] [Related]
88. Interferon-gamma production in Lyme arthritis synovial tissue promotes differentiation of fibroblast-like synoviocytes into immune effector cells.
Lochhead RB; Ordoñez D; Arvikar SL; Aversa JM; Oh LS; Heyworth B; Sadreyev R; Steere AC; Strle K
Cell Microbiol; 2019 Feb; 21(2):e12992. PubMed ID: 30550623
[TBL] [Abstract][Full Text] [Related]
89. Autoreactive T cells in rheumatic disease (1). Analysis of growth frequencies and autoreactivity of T cells in patients with rheumatoid arthritis and Lyme disease.
Schlesier M; Haas G; Wolff-Vorbeck G; Melchers I; Peter HH
J Autoimmun; 1989 Feb; 2(1):31-49. PubMed ID: 2787645
[TBL] [Abstract][Full Text] [Related]
90. Borrelia burgdorferi HSP70 homolog: characterization of an immunoreactive stress protein.
Anzola J; Luft BJ; Gorgone G; Dattwyler RJ; Soderberg C; Lahesmaa R; Peltz G
Infect Immun; 1992 Sep; 60(9):3704-13. PubMed ID: 1379988
[TBL] [Abstract][Full Text] [Related]
91. Heightened Proinflammatory Glycosylation of Borrelia burgdorferi IgG Antibodies in Synovial Fluid in Patients With Antibiotic-Refractory Lyme Arthritis.
Sanes JT; Costello CE; Steere AC
Arthritis Rheumatol; 2023 Jul; 75(7):1263-1274. PubMed ID: 36716113
[TBL] [Abstract][Full Text] [Related]
92. Lyme disease: an orthopedic perspective.
Lawrence SJ
Orthopedics; 1992 Nov; 15(11):1331-5. PubMed ID: 1461815
[TBL] [Abstract][Full Text] [Related]
93. Macrophages and enriched populations of T lymphocytes interact synergistically for the induction of severe, destructive Lyme arthritis.
DuChateau BK; Jensen JR; England DM; Callister SM; Lovrich SD; Schell RF
Infect Immun; 1997 Jul; 65(7):2829-36. PubMed ID: 9199456
[TBL] [Abstract][Full Text] [Related]
94. Trauma-related Lyme arthritis.
Roberts J; Merchant E
BMJ Case Rep; 2023 Jul; 16(7):. PubMed ID: 37407232
[TBL] [Abstract][Full Text] [Related]
95. Comparison of Borrelia burgdorferi ultrasonicate and whole B, burgdorferi cells as a stimulus for T-cell proliferation and GM-CSF secretion in vitro.
Schempp C; Owsianowski M; Lange R; Gollnick H
Zentralbl Bakteriol; 1993 Aug; 279(3):417-25. PubMed ID: 8219512
[TBL] [Abstract][Full Text] [Related]
96. Efficacy of clarithromycin for treatment of experimental Lyme disease in vivo.
Alder J; Mitten M; Jarvis K; Gupta P; Clement J
Antimicrob Agents Chemother; 1993 Jun; 37(6):1329-33. PubMed ID: 8328782
[TBL] [Abstract][Full Text] [Related]
97. E and P selectins are not required for resistance to severe murine lyme arthritis.
Seiler KP; Ma Y; Weis JH; Frenette PS; Hynes RO; Wagner DD; Weis JJ
Infect Immun; 1998 Sep; 66(9):4557-9. PubMed ID: 9712820
[TBL] [Abstract][Full Text] [Related]
98. Cellular immune response in Lyme disease: the response to mitogens, live Borrelia burgdorferi, NK cell function and lymphocyte subsets.
Dattwyler RJ; Thomas JA; Benach JL; Golightly MG
Zentralbl Bakteriol Mikrobiol Hyg A; 1986 Dec; 263(1-2):151-9. PubMed ID: 2953150
[TBL] [Abstract][Full Text] [Related]
99. IL-10 Deficiency Reveals a Role for TLR2-Dependent Bystander Activation of T Cells in Lyme Arthritis.
Whiteside SK; Snook JP; Ma Y; Sonderegger FL; Fisher C; Petersen C; Zachary JF; Round JL; Williams MA; Weis JJ
J Immunol; 2018 Feb; 200(4):1457-1470. PubMed ID: 29330323
[TBL] [Abstract][Full Text] [Related]
100. Lyme disease.
Athreya BH; Rose CD
Curr Probl Pediatr; 1996 Jul; 26(6):189-207. PubMed ID: 8866213
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
